Open AccessThe Role of Molecular Imaging in Personalised Healthcare
Author(s) -
Jason P. Holland
Publication year - 2016
Publication title -
chimia
Language(s) - English
Resource type - Journals
eISSN - 2673-2424
pISSN - 0009-4293
DOI - 10.2533/chimia.2016.787
Subject(s) - molecular imaging , positron emission tomography , perspective (graphical) , magnetic resonance imaging , health care , computer science , nanotechnology , medical physics , data science , computational biology , neuroscience , medicine , psychology , materials science , biology , artificial intelligence , radiology , political science , microbiology and biotechnology , in vivo , law
Functional molecular imaging provides a unique perspective on a disease. Methods including positron-emission tomography and magnetic resonance imaging allow us to interrogate spatial and temporal changes in biomarkers as well as probe the underlying biochemistry. When imaging is combined with molecular diagnostic tools, opportunities arise for measuring aberrant cellular signalling pathways with unprecedented detail. This brief commentary illustrates how radiotracers and nuclear imaging methods are being developed to monitor drug efficacy and simultaneously support the goal of personalised healthcare.